Liposome technology for cardiovascular disease treatment and diagnosis.

Abstract:

INTRODUCTION:Over the past several decades, liposomes have been used in a variety of applications, from delivery vehicles to cell membrane models. In terms of pharmaceutical use, they can offer control over the release of active agents encapsulated into their lipid bilayer or aqueous core, while providing protection from degradation in the body. In addition, liposomes are versatile carriers, because targeting moieties can be conjugated on the surface to enhance delivery efficiency. It is for these reasons that liposomes have been applied as carriers for a multitude of drugs and genetic material, and as contrast agents, aimed to treat and diagnose cardiovascular diseases. AREAS COVERED:This review details advancements in liposome technology used in the field of cardiovascular medicine. In particular, the application of liposomes to cardiovascular disease treatment and diagnosis, with a focus on delivering drugs, genetic material and improving cardiovascular imaging, will be explored. Advances in targeting liposomes to the vasculature will also be detailed. EXPERT OPINION:Liposomes may provide the means to deliver drugs and other pharmaceutical agents for cardiovascular applications; however, there is still a vast amount of research and clinical trials that must be performed before a formulation is brought to market. Advancements in targeting abilities within the body, as well as the introduction of theranostic liposomes, capable of both delivering treating and imaging cardiac diseases, may be expected in the future of this burgeoning field.

journal_name

Expert Opin Drug Deliv

authors

Bowey K,Tanguay JF,Tabrizian M

doi

10.1517/17425247.2012.647908

subject

Has Abstract

pub_date

2012-02-01 00:00:00

pages

249-65

issue

2

eissn

1742-5247

issn

1744-7593

journal_volume

9

pub_type

杂志文章,评审
  • Bacteriophages as vehicles for gene delivery into mammalian cells: prospects and problems.

    abstract:INTRODUCTION:The identification of more efficient gene delivery vehicles (GDVs) is essential to fulfill the expectations of clinical gene therapy. Bacteriophages, due to their excellent safety profile, extreme stability under a variety of harsh environmental conditions and the capability for being genetically manipulat...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.927437

    authors: Bakhshinejad B,Sadeghizadeh M

    更新日期:2014-10-01 00:00:00

  • Strategies for triggered drug release from tumor targeted liposomes.

    abstract:INTRODUCTION:Long circulating liposomal drug carriers are widely used in experimental cancer therapy because they avoid excretion and benefit from the enhanced permeability and retention-effect to accumulate at the tumor site while simultaneously limiting systemic exposure to the cytotoxic drug due to their high stabil...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.805742

    authors: Oude Blenke E,Mastrobattista E,Schiffelers RM

    更新日期:2013-10-01 00:00:00

  • Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicines.

    abstract:BACKGROUND:Pulmonary cell culture models for the development of new aerosol medicines are attracting increasing interest. Ease of handling, ethical acceptance and high explanatory power are the main advantages of cell culture systems in pulmonary drug research. OBJECTIVE:Pulmonary cell culture models are described and...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.6.641

    authors: Bur M,Lehr CM

    更新日期:2008-06-01 00:00:00

  • Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.

    abstract:IMPORTANCE OF THE FIELD:Drug combinations have been the standard of care in the treatment of cancer for > 50 years. Typically, combination chemotherapy uses agents with non-overlapping toxicities which are escalated to their maximum tolerated dose. However, emerging evidence indicates that this approach may not be prov...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.538678

    authors: Dicko A,Mayer LD,Tardi PG

    更新日期:2010-12-01 00:00:00

  • Bisphosphonate-modified biomaterials for drug delivery and bone tissue engineering.

    abstract:INTRODUCTION:Bisphosphonates (BPs) were introduced 45 years ago as anti-osteoporotic drugs and during the last decade have been utilized as bone-targeting groups in systemic treatment of bone diseases. Very recently, strategies of chemical immobilization of BPs in hydrogels and nanocomposites for bone tissue engineerin...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1021679

    authors: Ossipov DA

    更新日期:2015-01-01 00:00:00

  • Design and in vitro release study of siRNA loaded Layer by Layer nanoparticles with sustained gene silencing effect.

    abstract:OBJECTIVES:Clinical translation of siRNA therapeutics has been severely limited due to the lack of stable and sustained siRNA delivery systems. Furthermore, when nanocarrier systems with siRNA are administered systemically to treat diseases, insufficient doses reach the target tissue. Here we report the successful deve...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2018.1518426

    authors: Tan YF,Lee YS,Seet LF,Ng KW,Wong TT,Venkatraman S

    更新日期:2018-10-01 00:00:00

  • Controlled release using mesoporous materials containing gate-like scaffoldings.

    abstract::The use of gated mesoporous silica solids as suitable systems for controlled-release protocols is reviewed. These materials are based on mesoporous silica supports that can be prepared with tailor-made pores of around 2 - 10 nm and that show a very large specific surface area (up to 1200 m(2)/g), thus having a large l...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902895980

    authors: Aznar E,Martínez-Máñez R,Sancenón F

    更新日期:2009-06-01 00:00:00

  • Spray-congealed microparticles for drug delivery - an overview of factors influencing their production and characteristics.

    abstract:INTRODUCTION:In any manufacturing process, the success of producing an end product with the desired properties and yield depends on a range of factors that include the equipment, process and formulation variables. It is the interest of manufacturers and researchers to understand each manufacturing process better and as...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.915805

    authors: Oh CM,Guo Q,Wan Sia Heng P,Chan LW

    更新日期:2014-07-01 00:00:00

  • Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility.

    abstract:INTRODUCTION:Drug release and oral absorption of drugs with pH-dependent solubility are influenced by the conditions in the gastrointestinal tract. In some cases, poor oral absorption has been observed for these drugs, causing insufficient drug efficacy. The pH-modification of a formulation could be a promising approac...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.881798

    authors: Taniguchi C,Kawabata Y,Wada K,Yamada S,Onoue S

    更新日期:2014-04-01 00:00:00

  • Preclinical models for pulmonary drug delivery.

    abstract:BACKGROUND:The lung comprises an interesting route of administration not only for topical drugs but also for systemically acting drugs. Over the last years, several models have been developed in order to study the efficacy and safety of pulmonary drug delivery. OBJECTIVE:This review describes relevant drug delivery mo...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903241788

    authors: Fernandes CA,Vanbever R

    更新日期:2009-11-01 00:00:00

  • New biomaterials for the sustained release of nitric oxide: past, present and future.

    abstract::Nitric oxide (NO), the 1992 'Molecule of the Year', is the focus of immense medical and scientific exploration. Interest in NO has grown exponentially since the initial and relatively recent discovery that NO is the long sought after endothelial relaxing factor. There is intense research that is continuing to expose t...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903196743

    authors: Friedman A,Friedman J

    更新日期:2009-10-01 00:00:00

  • Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.

    abstract:BACKGROUND:Pressurized metered-dose inhalers (pMDIs) include hydrofluoroalkane (HFA) propellant to generate a drug aerosol upon actuation and drugs can be formulated as solution or suspension. Suspended particles can cream or sediment depending on density differences between drug and propellant and shaking the pMDI is ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1767066

    authors: Chierici V,Cavalieri L,Piraino A,Paleari D,Quarta E,Sonvico F,Melani AS,Buttini F

    更新日期:2020-07-01 00:00:00

  • Process optimization for the production of nanoparticles for drug delivery applications.

    abstract::Various techniques have been developed to prepare nanoparticles for the delivery of drugs. The implementation of these techniques for large-scale production is still in its infancy, as it requires defined steps which include excipient compatibility, process feasibility, formulation optimization, process optimization, ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902735806

    authors: Saraf S

    更新日期:2009-02-01 00:00:00

  • Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.

    abstract:INTRODUCTION:A nanosuspension or nanocrystal suspension is a versatile formulation combining conventional and innovative features. It comprises 100% pure drug nanoparticles with sizes in the nano-scale range, generally stabilized by surfactants or polymers. Nanosuspensions are usually obtained in liquid media with bott...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1043886

    authors: Leone F,Cavalli R

    更新日期:2015-01-01 00:00:00

  • Novel functionalization strategies to improve drug delivery from polymers.

    abstract:INTRODUCTION:The utility of controlled and sustained release of drugs from polymeric systems, both bulk (hydrogels) and colloids (nanoparticles), is a key point that should be addressed. Unfortunately, classic delivery systems are essentially driven by diffusion, which is very quick due to the high concentration gradie...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1285280

    authors: Mauri E,Papa S,Masi M,Veglianese P,Rossi F

    更新日期:2017-11-01 00:00:00

  • Disease guided optimization of the respiratory delivery of microparticulate formulations.

    abstract:BACKGROUND:Inhalation of microparticulate dosage forms can be effectively used in the treatment of respiratory and systemic diseases. OBJECTIVE:Disease states investigated for treatment by inhalation of microparticles were reviewed along with the drugs' pharmacological, pharmacokinetic and physical chemical properties...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.5.3.269

    authors: Xie Y,Zeng P,Wiedmann TS

    更新日期:2008-03-01 00:00:00

  • Transdermal delivery of calcium channel blockers for hypertension.

    abstract:INTRODUCTION:Calcium channel blockers are a very important class of antihypertensive drugs. Most calcium channel blockers (CCBs) exhibiting low oral bioavailability are required to be taken more than once a day due to their short half-lives which result in poor patient compliance. There is an ineluctable requirement fo...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.783562

    authors: Ahad A,Al-Jenoobi FI,Al-Mohizea AM,Aqil M,Kohli K

    更新日期:2013-08-01 00:00:00

  • Targeting drugs to the airways: The role of spacer devices.

    abstract:AIM:Spacer devices are inhalation aids of varying dimension and complexity, specifically designed to overcome problems with the use of pressurised metered dose inhalers (pMDIs). The aim of this review is to examine the current understanding about these inhalation devices and discuss their advantages and disadvantages. ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240802637862

    authors: Lavorini F,Fontana GA

    更新日期:2009-01-01 00:00:00

  • Noninvasive approach for enhancing small interfering RNA delivery percutaneously.

    abstract:INTRODUCTION:Topically applied small interfering RNA (siRNA) can be an effective treatment for skin disorders. Using noninvasive strategies can be a safe and effective siRNA-permeation-enhancement approach for facilitating skin delivery. It has been demonstrated that noninvasive approaches for enhancing siRNA transport...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2016.1121988

    authors: Aljuffali IA,Lin YK,Fang JY

    更新日期:2016-01-01 00:00:00

  • New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.

    abstract:INTRODUCTION:Inflammatory bowel disease (IBD) is an exceptional scenario with regard to drug targeting, as oral administration has the potential to deliver the drug directly to the site(s) of action. Consequently, retention of the drug within the intestinal lumen and tissue, rather than systemic absorption, is frequent...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.800480

    authors: Wolk O,Epstein S,Ioffe-Dahan V,Ben-Shabat S,Dahan A

    更新日期:2013-09-01 00:00:00

  • Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them.

    abstract::Introduction: Peritoneal metastases of cancer remain a major cause of an adverse outcome and death following surgical treatment of malignancies that occur within the abdomen and pelvis. The administration of a chemotherapy solution directly into the peritoneal space has been used to improve the survival in this group ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1693997

    authors: Sugarbaker PH

    更新日期:2019-12-01 00:00:00

  • Recent advances in the targeting of systemically administered non-viral gene delivery systems.

    abstract::Introduction: Systemically administered non-viral gene delivery systems face multiple biological barriers that decrease their efficiency. These systems are rapidly cleared from the circulation and sufficient concentrations do not accumulate in diseased tissues. A number of targeting strategies can be used to provide f...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1656196

    authors: Khalil IA,Sato Y,Harashima H

    更新日期:2019-10-01 00:00:00

  • Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.

    abstract:INTRODUCTION:Recent developments in ultrasound imaging and ultrasound contrast agents (UCAs) improved diagnostic confidence in echography and set into motion their combined use as a tool for drug delivery and therapeutic monitoring. Non-invasive, precise and targeted delivery of drug molecules to pathological tissues b...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2017.1266328

    authors: Sennoga CA,Kanbar E,Auboire L,Dujardin PA,Fouan D,Escoffre JM,Bouakaz A

    更新日期:2017-09-01 00:00:00

  • Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell.

    abstract:INTRODUCTION:Macromolecular therapeutics, including enzymes, transcription factors, siRNAs, peptides and large synthetic molecules, can potentially be used to treat human diseases by targeting intracellular molecular pathways and modulating biological responses. However, large macromolecules have no ability to enter ce...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2015.1046431

    authors: Lönn P,Dowdy SF

    更新日期:2015-01-01 00:00:00

  • Drug delivery strategies for therapy of visceral leishmaniasis.

    abstract:IMPORTANCE OF THE FIELD:Visceral leishmaniasis (VL) is the most overwhelming type of leishmaniasis associated with the poverty of developing countries and usually mortal if untreated. Most of the conventionally used dosage forms offer us the shortcomings of toxic side effects and emergence of drug resistance. Several e...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903548232

    authors: Gupta S,Pal A,Vyas SP

    更新日期:2010-03-01 00:00:00

  • Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.

    abstract:BACKGROUND:The present work focuses on the development of ultra-small solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) encapsulating cyclosporine and calcipotriol, further incorporated into gel, increasing their penetration through the skin. RESEARCH DESIGN AND METHODS:Developed SLN and NLC were...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2017.1264386

    authors: Arora R,Katiyar SS,Kushwah V,Jain S

    更新日期:2017-02-01 00:00:00

  • Antibiotic uptake through porins located in the outer membrane of Gram-negative bacteria.

    abstract::Introduction: Making selective inhibitors of novel Gram-negative targets is not a substantial challenge - getting them into Gram-negative bacteria to reach their lethal target is the bottleneck. Poor permeability of the antibiotic requires high concentration causing off target activity. The lack of simple experimental...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2021.1847080

    authors: Winterhalter M

    更新日期:2020-11-13 00:00:00

  • The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis.

    abstract::Introduction: Cisplatin has been indicated for several malignancies all over the world for many years. Increasing patient tolerance for high dose of chemotherapeutics and reducing side effects has been granted by drug encapsulated liposomal systems. There have been much efforts for improving cisplatin delivery to the ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1737672

    authors: Zahednezhad F,Zakeri-Milani P,Shahbazi Mojarrad J,Valizadeh H

    更新日期:2020-04-01 00:00:00

  • A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states.

    abstract::Introduction: Sativex® spray is clinically utilized to deliver delta9-tetrahydrocannabinol and cannabidiol to oral mucosa for systemic absorption. We challenge the consensus that the mechanism of absorption following the oro-mucosal application occurs via the buccal tissue. Areas covered: Correctness of the consensus ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1653852

    authors: Itin C,Domb AJ,Hoffman A

    更新日期:2019-10-01 00:00:00

  • Role of in vitro release models in formulation development and quality control of parenteral depots.

    abstract::This review article provides an assessment of advantages/limitations of the use of current in vitro release models to predict in vivo performance of parenteral sustained release products (injectable depots). As highlighted, key characteristics influencing the in vivo drug fate may vary with the route of administration...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903307431

    authors: Larsen C,Larsen SW,Jensen H,Yaghmur A,Ostergaard J

    更新日期:2009-12-01 00:00:00